Pablo Guzman Power - 26 Jan 2023 Form 3 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Chief Medical Officer
Signature
/s/ Pablo Guzman
Issuer symbol
ZVSA
Transactions as of
26 Jan 2023
Net transactions value
$0
Form type
3
Filing time
26 Jan 2023, 19:22:23 UTC
Next filing
15 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZVSA Common Stock 26,021 26 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 2,978 $5.03 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 9,927 $5.03 Direct F1
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 19,854 $11.58 Direct F2
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 11,019 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 2,912 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 4,368 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 4,368 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 4,368 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 4,368 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 4,368 $16.36 Direct
holding ZVSA Stock Option (Right to Buy) 26 Jan 2023 Common Stock 4,368 $11.33 Direct
holding ZVSA Warrant (Right to Buy) 26 Jan 2023 Common Stock 9,015 $6.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on January 22, 2016.
F2 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 1, 2020.

Remarks:

Exhibit 24- Power of Attorney